Loading data for LONA — first visit, this takes a few seconds.
LeonaBio, Inc. (LONA)
NasdaqCM: LONA
· Real-Time Price · USD
7.56
-0.14 (-1.82%)
At close: Sep 04, 2026, 8:00 PM
7.56
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
LeonaBio, Inc. (LONA) Stock Price, Analysis & Data
No data available
| Bid | 7.53 |
| Market Cap | 71.2M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -141M |
| 2.05 | |
| -23.01 | |
| n/a | |
| n/a | |
| P/B (ttm) | 2.12 |
| P/S (ttm) | 0.00 |
| Earnings Date | Aug 6, 2026 |
| Ask | 8.12 |
| Volume | 14,230 |
| Avg. Volume (20D) | 36,657 |
| Open | 7.92 |
| Previous Close | 7.70 |
| Day's Range | 7.44 - 7.92 |
| 52-Week Range | 3.53 - 14.21 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About LONA
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipe...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 18, 2020
Employees 19
Stock Exchange NasdaqCM
Ticker Symbol LONA
Website https://www.leonabio.com
Financial Performance
In 2025, LeonaBio's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -105.61M, an increase of 8.94%.
Financial StatementsEarnings Surprise
LeonaBio has released their quarterly earnings on Aug 14, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.8 exceeds estimates by 0.56, with 55.56% YoY growth.
LeonaBio, Inc. is scheduled to release its earnings on Aug 6, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
